Indivior Pharmaceuticals (INDV) Amortizatization of Intangibles (2024 - 2026)
Indivior Pharmaceuticals (INDV) recorded quarterly Amortizatization of Intangibles of $2.0 million in Q1 2026, down 33.33% quarter-over-quarter from $3.0 million in Q4 2025, and little changed on a YoY basis from $2.0 million in Q1 2025.
Indivior Pharmaceuticals (INDV) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles changed 0.0% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $10.0 million (changed N/A YoY), while the FY2025 annual figure was $10.0 million, down 16.67% from the prior year.
- Amortizatization of Intangibles was $2.0 million for Q1 2026 at Indivior Pharmaceuticals, down from $3.0 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $4.0 million in Q3 2024 to a low of $2.0 million in Q1 2025.
- Historically, Amortizatization of Intangibles has averaged $2.9 million across 3 years, with a median of $3.0 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles sank 50.0% in 2025, then changed 0.0% in 2026.
- A 3-year view of Amortizatization of Intangibles shows it stood at $4.0 million in 2024, then decreased by 25.0% to $3.0 million in 2025, then sank by 33.33% to $2.0 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $2.0 million (Q1 2026), $3.0 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Indivior Pharmaceuticals | - | - | 277.00 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Sep 30, 2024 | 4.00 Mn |